UPM Institutional Repository

Antidiabetic potentials of gypenosides: A review on the preclinical effects in glucose and insulin modulation as well as diabetes-related complications


Citation

Lee, Yu Zhao and Kow, Audrey Siew Foong and Lee, Qi Long and Lim, Luis Wei Cheng and Yusof, Rohana and Tham, Chau Ling and Ho, Yu Cheng and Lee, Ming Tatt (2025) Antidiabetic potentials of gypenosides: A review on the preclinical effects in glucose and insulin modulation as well as diabetes-related complications. Naunyn-Schmiedeberg's Archives of Pharmacology, 398 (11). pp. 14813-14829. ISSN 0028-1298; eISSN: 1432-1912

Abstract

Purpose: Diabetes mellitus is a significant public health issue. Despite the emergence of promising anti-hyperglycemic drugs, treatment outcomes for diabetic patients continue to be inadequate. Gypenosides are the major bioactive compounds isolated from Gynostemma pentaphyllum (Thunb.) Makino. Gynostemma pentaphyllum has longstanding history of usage in traditional oriental medicine, particularly for the treatment of diabetes mellitus. Gypenosides were found to exhibit antidiabetic effects. This review outlined the advancements in the preclinical studies of gypenosides’ pharmacological properties on diabetes mellitus and their potential mechanism of action, while also noting the lack of clinical evidence for gypenosides’ efficacy. Methods: Literatures search was done using scientific databases PubMed, Web of Science, Scopus and Google Scholar up to November 2024 utilizing keywords such as "Gynostemma pentaphyllum", "gypenoside*", and "diabet*". Results: Research has shown that gypenosides possess therapeutic properties in mitigating diabetes mellitus by regulating blood glucose levels and insulin production. Gypenosides can modulate various key pathways associated with diabetes pathogenesis, including PI3K/Akt, PPARγ, NF-κB, AMPK and PDX1, hence contributing to their antidiabetic properties. Nevertheless, there is a paucity of research on gypenosides in clinical settings, with existing studies being mainly conducted on animal models and in vitro. Future studies with the focus on the isolation and purification of specific gypenosides, as well as the exploration on the probable pharmacological effect and molecular mechanisms behind the biological actions are necessary. Conclusion: The findings presented may establish a foundation for subsequent clinical trials for the development of specific gypenosides as antidiabetic therapies for the betterment of human health.


Download File

[img] Text
122381.pdf - Published Version

Download (1MB)

Additional Metadata

Item Type: Article
Subject: Pharmacology
Divisions: Faculty of Medicine and Health Science
Institute of Bioscience
DOI Number: https://doi.org/10.1007/s00210-025-04265-x
Publisher: Springer Science and Business Media Deutschland
Keywords: Antidiabetic; Diabetes mellitus; Diabetic complication; Gynostemma pentaphyllum; Gypenoside
Depositing User: Ms. Nur Faseha Mohd Kadim
Date Deposited: 15 Jan 2026 02:15
Last Modified: 15 Jan 2026 02:15
Altmetrics: http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.1007/s00210-025-04265-x
URI: http://psasir.upm.edu.my/id/eprint/122381
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item